NCT06027775View on ClinicalTrials.gov

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as Adjuvant Therapy for Initially Unresectable Colorectal Cancer Liver Metastases

CompletedOBSERVATIONAL

Enrollment

198

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

January 1, 2023

Study Completion Date

January 1, 2023

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG

Targeted agent

The two cohorts received different adjuvant therapy regimens, with the CT group receiving chemotherapy plus targeted therapy; the CA group received chemotherapy alone.

All Listed Sponsors

lead

Fudan University

OTHER

NCT06027775 - Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as Adjuvant Therapy for Initially Unresectable Colorectal Cancer Liver Metastases | Biotech Hunter | Biotech Hunter